Skip to content
Ranked #62
SnagRx

People who want compounded semaglutide or tirzepatide at a price that stays flat at every dose, and who will check the plan length before paying.

semaglutide
$99/mosee conditions
tirzepatide
$149/mosee conditions
Before enrolling

The home page advertises $69/mo and $119/mo with no plan length beside them; its terms say those are 12-month rates billed as $828 and $1,428 once, and the monthly-billed rates are $99 and $149

vs
Ranked #111
Vitara RX

Lowest flat-rate compounded GLP-1 from a certified marketplace.

semaglutide
$99/mo
tirzepatide
$149/mo
Before enrolling

No corporate legal entity disclosed — only the trade name "VitaraRx"

Our review of SnagRx gives it 77/100, and our review of Vitara RX gives it the same score. Compare the individual scores and plan terms below to see where the two providers differ.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

SnagRx

77/100

C+

Overall

Vitara RX

77/100

C+

Price transparency

78
94

State access

86
78

Molecule range

66
66

Onboarding speed

75
77

Support responsiveness

79
61

Licensing & trust

78
73

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldSnagRxVitara RX
Semaglutide$99/mosee conditions
Full plan terms

$99/mo (billed monthly, flat at every dose, compounded; prepaid plans per its terms: 3 months $89/mo billed as $267 once; 6 months $79/mo billed as $474 once; 12 months $69/mo billed as $828 once; the $69 on its home page is the 12-month rate, shown under a Pre-Black Friday sale banner)

$99/mo
Full plan terms

$99/mo

Tirzepatide$149/mosee conditions
Full plan terms

$149/mo (billed monthly, flat at every dose, compounded; prepaid plans per its terms: 3 months $139/mo billed as $417 once; 6 months $129/mo billed as $774 once; 12 months $119/mo billed as $1,428 once; the $119 on its home page is the 12-month rate, shown under a Pre-Black Friday sale banner)

$149/mo
Full plan terms

$149/mo

CoverageAll 50 states plus Washington D.C. per its terms; its FAQ says every state except Louisiana, and Nebraska only for patients 19 or older49 states
Brand-nameNot confirmed hereNot confirmed here
Oral optionNot confirmed hereNot confirmed here
Best forPeople who want compounded semaglutide or tirzepatide at a price that stays flat at every dose, and who will check the plan length before paying.Lowest flat-rate compounded GLP-1 from a certified marketplace.
Desk Score77/100C+77/100C+

The verdict

Too close to call

The overall scores are tied. Check the available products, payment terms and state coverage before choosing.

Choose SnagRx if…

People who want compounded semaglutide or tirzepatide at a price that stays flat at every dose, and who will check the plan length before paying.

$99/mo (see conditions) sema · $149/mo (see conditions) tirz · All 50 states plus Washington D.C. per its terms; its FAQ says every state except Louisiana, and Nebraska only for patients 19 or older

Choose Vitara RX if…

Lowest flat-rate compounded GLP-1 from a certified marketplace.

$99/mo sema · $149/mo tirz · 49 states

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.